Mark Chin

Insider Reports History

Location
London, United Kingdom
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Chin:

Company Role Class Num Shares Value Price $ Report Date Ownership
IMARA Inc. Director Common Stock 2,344,072 $35,477,530 $15.14 02 Jun 2022 By entities affiliated with Arix Bioscience plc
Pyxis Oncology, Inc. Former Director Stock Option (Right to buy) 42,191 $161,592 $3.83 07 Oct 2021 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 $32,200 $1.40 11 Mar 2024 Direct
Iterum Therapeutics plc Director Ordinary Shares 18,306 $25,628 $1.40 15 Jun 2023 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 $0 $23.00 11 Mar 2024 Direct
Disc Medicine, Inc. Director Stock Option (Right to Buy) 10,000 11 Jun 2025 Direct
IMARA Inc. Director Stock Options (Right to Buy) 8,500 02 Jun 2022 Direct
Iterum Therapeutics plc Director Restricted Share Units 0 15 Jun 2023 Direct
Pyxis Oncology, Inc. Former Director Common Stock 0 $1.40 21 Apr 2022 Indirect
Pyxis Oncology, Inc. Former Director Series B Convertible Preferred Stock 0 13 Oct 2021 Indirect

Insider Reports Filed by Mark Chin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRON Disc Medicine, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 17:18
IRON Disc Medicine, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:15
/report/000095017024029439-chin-mark-2024-03-08 Harpoon Therapeutics, Inc. 08 Mar 2024 6 $0 4 Director 11 Mar 2024, 17:22
/report/000095017024000959-chin-mark-2024-01-01 Harpoon Therapeutics, Inc. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 16:30
/report/000120919123056794-chin-mark-2023-11-27 Harpoon Therapeutics, Inc. 27 Nov 2023 1 $0 4 Director 28 Nov 2023, 16:23
/report/000120919123051148-chin-mark-2023-10-01 Harpoon Therapeutics, Inc. 01 Oct 2023 1 $0 4 Director 02 Oct 2023, 17:34
/report/000120919123041673-chin-mark-2023-07-01 Harpoon Therapeutics, Inc. 01 Jul 2023 1 $0 4 Director 06 Jul 2023, 18:37
/report/000120919123039404-chin-mark-2023-06-22 Harpoon Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:29
ITRM Iterum Therapeutics plc 15 Jun 2023 2 $0 4 Director 15 Jun 2023, 17:00
IRON Disc Medicine, Inc. 09 Jun 2023 1 $0 4 Director 09 Jun 2023, 18:31
/report/000120919123022794-chin-mark-2023-04-01 Harpoon Therapeutics, Inc. 01 Apr 2023 1 $0 4 Director 04 Apr 2023, 17:02
IRON Disc Medicine, Inc. 29 Dec 2022 1 $0 4 Director 03 Jan 2023, 16:12
IRON Disc Medicine, Inc. 29 Dec 2022 0 $0 3 Director 03 Jan 2023, 16:00
ITRM Iterum Therapeutics plc 23 Jun 2022 2 $0 4 Director 24 Jun 2022, 18:00
/report/000120919122039323-chin-mark-2022-06-22 Harpoon Therapeutics, Inc. 22 Jun 2022 2 +$44,999 4 Director 24 Jun 2022, 18:42
ITRM Iterum Therapeutics plc 15 Jun 2022 1 +$2,378 4 Director 17 Jun 2022, 17:01
ELVN IMARA Inc. 02 Jun 2022 1 $0 4 Director 03 Jun 2022, 20:19
PYXS Pyxis Oncology, Inc. 21 Apr 2022 1 -$5,324,571 4 Former Director 25 Apr 2022, 12:12
PYXS Pyxis Oncology, Inc. 31 Mar 2022 1 $0 4 Director 04 Apr 2022, 16:15
PYXS Pyxis Oncology, Inc. 13 Oct 2021 3 +$5,000,000 4 Director 15 Oct 2021, 17:37
PYXS Pyxis Oncology, Inc. 07 Oct 2021 1 $0 4 Director 12 Oct 2021, 19:47
PYXS Pyxis Oncology, Inc. 07 Oct 2021 0 $0 3 Director 07 Oct 2021, 20:56
ELVN IMARA Inc. 16 Jul 2021 1 +$7,999,998 4 Director 28 Jul 2021, 08:50
ELVN IMARA Inc. 29 Jun 2021 1 $0 4 Director 30 Jun 2021, 18:41
ITRM Iterum Therapeutics plc 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 16:06
/report/000120919121032951-chin-mark-2021-05-04-restatement Harpoon Therapeutics, Inc. 04 May 2021 2 $0 4/A Director 14 May 2021, 19:57